HGP2102

· Hanmi Pharmaceutical Company Limited

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HGP2102, covering 2025-06-12 to 2025-06-12. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate Efficacy and Safety of HGP2102 in Essential Hypertension Patients [Phase 3]